Skip to main content

Table 2 Rates of acute and late adverse events among prostate cancer patients (n = 110)

From: Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system

Grade

Acute

Late

  

0

1

2

3

0

1

2

3

GI

Total

103

7

0

0

102

8

0

0

93.6%

6.4%

0%

0%

92.7%

7.3%

0%

0%

 

Rectal mucositis/pain

 

7

      
 

Rectal bleeding

      

8

 

GU

Total

55

44

1

0

90

17

3

0

50.0%

40.0%

0.9%

0%

81.8%

15.5%

2.7%

0%

 

Frequency

 

30

1

     

Cystitis noninfective

 

27

   

11

1

 

Retention/obstruction

 

12

    

1

 

Urgency

 

14

1

  

7

1

 

Urethral tract pain

 

12

      
  1. GI, gastrointestinal; GU, genitourinary. Acute (AE): originating within 90 days from the completion of radiation therapy. Late (AE): appearing more than 90 days from the completion of radiation therapy.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us